Halozyme Therapeutics shares owned by Allspring Global Investments Holdings
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Allspring Global Investments Holdings
from 13F filings
Historical chart of Allspring Global Investments Holdings investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Allspring Global Investments Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Allspring Global Investments Holdings
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $28M | 696k | 40.68 |
| 2023-12-31 | $27M | 728k | 36.96 |
| 2023-09-30 | $34M | 887k | 38.20 |
| 2023-06-30 | $12M | 323k | 36.07 |
| 2023-03-31 | $9.3M | 243k | 38.19 |
| 2022-12-31 | $23M | 398k | 56.90 |
| 2022-09-30 | $29M | 744k | 39.54 |
| 2022-06-30 | $28M | 626k | 44.00 |
| 2022-03-31 | $28M | 699k | 39.88 |
| 2021-12-31 | $36M | 890k | 40.21 |
More positions owned by Allspring Global Investments Holdings
View all positions for Allspring Global Investments Holdings